GliaCure’s participation in the 2012 BIO International Convention in Boston was very successful. The booth included a triptych backdrop with the central banner asking, “Are You GliaCurious?” Looping iPad presentations attracted attention and resultant traffic at the booth was great. President Phil Haydon and VP Mike Szulczewski were busy with in-booth meetings with representatives from…more »
GliaCure is preparing for the 2012 BIO International Convention that runs from Monday, June 18 through Thursday, June 21 in the Boston Convention & Exhibition Center in the Boston Innovation District. GliaCure has set up its booth at the Convention Center and will be participating in more than 20 partnering meetings. Check back for pictures…more »
On May 10, 2012 an article by was published by a research group in the journal Cerebral Cortex. This paper details a study in human brain tissue showing that bidirectional signaling takes place between neurons and astrocytes. Cerebral Cortex is not an open access journal, so the full report is available only to subscribers; however,…more »
On May 15, 2012 Health and Human Services Secretary Kathleen Sebelius announced new funding initiatives to aid in the fight against Alzheimer’s disease. The plan, presented at the Alzheimer’s Research Summit 2012, includes funding of new research projects, tools for clinicians, easier access to information for caregivers and an awareness campaign.
GliaCure will be participating in the 2012 BIO International Convention, June 18-21 at the Boston Convention & Exhibition Center, MA. Owners Phil Haydon and Mike Szulczewski will be available to meet with company representatives interested in GliaCure’s research and drug development and to discuss potential partnering opportunities.
GliaCure announced that it has closed its first round of funding. The announcement was published on the MassBio site.
Walter Dewey received his B.B.A. in Finance in 1983 from the University of Wisconsin-Madison. He is CEO and Chief Investment Strategist of Resonant Capital Advisors, which he co-founded in 2018. Prior to this, Walter held key positions in investment and wealth management firms for over thirty years. His positions have included Vice- President and Portfolio…more »
GliaCure President Michael Szulczewski received his BSEE with a major option in integrated circuits and electron devices in 1981 from the University of Wisconsin – Madison. Mike was also the President and co-Founder of Prairie Technologies, Inc. Based in Madison, Wisconsin, Prairie manufactures, sells and supports laser microscopy instruments worldwide for use in cell biology…more »
Philip Haydon is President of GliaCure and the Annetta and Gustav Grisard Professor and Chair in the Department of Neuroscience at Tufts. In 1994 Phil Haydon’s laboratory discovered that astrocytes can release the chemical transmitter glutamate in response to receptor-induced Ca2+ elevations and that this glial-mediated signal can activate neighboring neurons. Since then his studies…more »
Abstract – Astroglial cells, due to their passive electrical properties, were long considered subservient to neurons and to merely provide the framework and metabolic support of the brain. Although astrocytes do play such structural and housekeeping roles in the brain, these glial cells also contribute to the brain’s computational power and behavioural output. These more…more »